These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17936884)

  • 1. Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.
    Winter JC
    Pharmacol Biochem Behav; 2008 Jan; 88(3):189-95. PubMed ID: 17936884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC; Eckler JR; Rabin RA
    Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.
    Winter JC; Eckler JR; Rice KC; Rabin RA
    Pharmacol Biochem Behav; 2005 Jul; 81(3):694-700. PubMed ID: 15970314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocybin-induced stimulus control in the rat.
    Winter JC; Rice KC; Amorosi DJ; Rabin RA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):472-80. PubMed ID: 17688928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.
    Winter JC; Doat M; Rabin RA
    Life Sci; 2000 Dec; 68(3):337-44. PubMed ID: 11191649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
    Swedberg MD; Ellgren M; Raboisson P
    J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors.
    Mori A; Noda Y; Mamiya T; Miyamoto Y; Nakajima A; Furukawa H; Nabeshima T
    Behav Brain Res; 2001 Feb; 119(1):33-40. PubMed ID: 11164523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys.
    Jones HE; Li H; Balster RL
    Pharmacol Biochem Behav; 1998 Feb; 59(2):413-8. PubMed ID: 9476989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S; Filipink RA; Bowen WD; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interactions between 'club drugs': gamma-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects.
    Koek W; Khanal M; France CP
    Behav Pharmacol; 2007 Dec; 18(8):807-10. PubMed ID: 17989519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists.
    Koek W; France CP
    Psychopharmacology (Berl); 2008 Aug; 199(2):191-8. PubMed ID: 18446324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats.
    Nicholson KL; Balster RL
    Psychopharmacology (Berl); 2003 Nov; 170(2):215-24. PubMed ID: 12851738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the discriminative stimulus effects of the low-affinity N-methyl-D-aspartate channel blockers AR-R 13950AA and AR-R 16283AA in rats and rhesus monkeys.
    Nicholson KL; Balster RL
    Behav Pharmacol; 2002 Nov; 13(7):571-81. PubMed ID: 12409995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine.
    Beardsley PM; Balster RL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):34-40. PubMed ID: 3336008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of dopaminergic system in the nucleus accumbens in the discriminative stimulus effects of phencyclidine.
    Mori A; Noda Y; Nagai T; Mamiya T; Furukawa H; Nabeshima T
    Neuropharmacology; 2002 May; 42(6):764-71. PubMed ID: 12015202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
    Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
    J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Eckler JR; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.